» Articles » PMID: 17574388

Evidence for Neuronal Dysfunction in the Anterior Cingulate of Patients with Schizophrenia: a Proton Magnetic Resonance Spectroscopy Study at 3 T

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2007 Jun 19
PMID 17574388
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The anterior cingulate region is thought to be dysfunctional in schizophrenia, but whether this is the result of reduced neuronal integrity or changes in neurotransmitter systems remains an issue of debate. Fifteen male patients with schizophrenia and 14 male controls were assessed using proton magnetic resonance spectroscopy, with regions of interest placed in the right and left dorsal and rostral cingulate. The metabolites of interest were N-acetylaspartate (NAA), a putative neuronal marker, and glutamate + glutamine (Glx), which may index synapse number. Schizophrenia patients had lower NAA concentrations throughout the dorsal and rostral portions of the anterior cingulate and in both hemispheres, but showed no changes in Glx. Anterior cingulate involvement in schizophrenia is likely to be a result of neuronal loss or dysfunction.

Citing Articles

Meta-analytic evidence of elevated choline, reduced N-acetylaspartate, and normal creatine in schizophrenia and their moderation by measurement quality, echo time, and medication status.

Yang Y, Smucny J, Zhang H, Maddock R Neuroimage Clin. 2023; 39:103461.

PMID: 37406595 PMC: 10509531. DOI: 10.1016/j.nicl.2023.103461.


Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis.

Merritt K, McCutcheon R, Aleman A, Ashley S, Beck K, Block W Mol Psychiatry. 2023; 28(5):2039-2048.

PMID: 36806762 PMC: 10575771. DOI: 10.1038/s41380-023-01991-7.


Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of H-magnetic resonance spectroscopy studies.

Nakahara T, Tsugawa S, Noda Y, Ueno F, Honda S, Kinjo M Mol Psychiatry. 2021; 27(1):744-757.

PMID: 34584230 DOI: 10.1038/s41380-021-01297-6.


Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data.

Merritt K, McGuire P, Egerton A, Aleman A, Block W, Bloemen O JAMA Psychiatry. 2021; 78(6):667-681.

PMID: 33881460 PMC: 8060889. DOI: 10.1001/jamapsychiatry.2021.0380.


Aberrant Dynamic Functional Connectivity of Default Mode Network in Schizophrenia and Links to Symptom Severity.

Sendi M, Zendehrouh E, Ellis C, Liang Z, Fu Z, Mathalon D Front Neural Circuits. 2021; 15:649417.

PMID: 33815070 PMC: 8013735. DOI: 10.3389/fncir.2021.649417.